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RELATO DE CASO | CASE REPORT
Danish type gelsolin-related amyloidosis in a Brazilian family: case reports
Amiloidose familiar relacionada ao gene gelsolin em uma família brasileira: relato de casos
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ABSTRACT
Familial amyloidosis of the Finnish type (FAF) is an autosomal dominant form of
systemic amyloidosis showing marked geographic clustering in Finland. The disease
is caused by a point mutation, 654G-A, in the gelsolin gene. The Danish-subtype of
FAF has been previously described in three families, the patients present clinical
findings similar to FAF, and the mutation 654G-T in the gelsolin gene. Three members
from two generations of the same family, with familial amyloidosis, were screened for
mutations in the GSN gene. Genomic DNA was extracted from peripheral blood
lymphocytes and the polymerase chain reaction (PCR) was carried out under standard
conditions, using appropriate primers. Sequence analysis showed the presence of a
G to T transition at nucleotide 654 of the gelsolin gene. This is the first report of
gelsolin-related familial amyloidosis in a Brazilian family, and the result is particularly
significant as this pedigree presents an unusual mutation, described previously in
three families, with no known Finnish ancestors (Danish type).
Keywords: Amyloidosis; Gelsolin; Corneal dystrophies, hereditary; Cornea/pathology;
Humans; Female; Male; Adult; Case reports
RESUMO
Amiloidose familiar do tipo finlandes (FAF) é uma forma de amiloidose sistêmica au-
tossômica dominante com grande concentração geográfica na Finlândia. É causada por
uma mutação, 654G-A, no gene gelsolin. O subtipo dinamarquês da FAF foi previamente
descrito em três famílias, com achados clínicos similares mas com a mutação 654G-T no gene
gelsolin. Três membros de duas gerações da mesma família, com diagnóstico de amiloidose
familiar, foram submetidos a screening de mutações no gene gelsolin. O DNA genômico
foi extraído de linfócitos do sangue periférico, sendo realizada reação em cadeia de
polimerase (PCR) em condições padronizadas. A análise do sequenciamento revelou uma
transição de G para T no nucleotidio 654 do gene gelsolin. Este é o primeiro relato de uma
amiloidose familiar relacionada ao gene gelsolin em uma família brasileira, que apresen-
ta uma forma rara de mutação, descrita previamente em três famílias, sem ancestrais
finlandeses (tipo dinamarquês).
Descritores: Amiloidose; Gelsolina; Distrofia hereditária da córnea; Córnea/patologia;
Humano; Feminino; Masculino; Adulto; Relato de casos
INTRODUCTION
Gelsolin-related familial amyloidosis, also known as familial
amyloidosis of the Finnish type (FAF) or Meretoja syndrome, is an
autosomal dominant form of systemic amyloidosis characterized by
corneal lattice dystrophy, progressive cranial and peripheral neu-
ropathy, skin changes (cutis laxa), renal and cardiac manifestations(1-3).
Corneal lattice dystrophy is usually the earliest clinical finding and
is characterized by amyloid deposit within the stroma. The hetero-
zygous patients often present with ophthalmological disturbances
in the third or fourth decade of life, while the homozygotes present
with earlier onset, and greater severity of clinical findings(1,4). These
clinical manifestations are the result of accumulation of amyloid
fibrils derived from the actin-regulating protein gelsolin, which exists
in two different forms, cytoplasmic or plasma, derived from the
same gene by alternative splicing. The pathogenesis of the FAF
disease phenotype arises from the accumulation of extracellular
amyloid in tissues rather than the loss of gelsolin function.
Gelsolin-related familial amyloidosis is caused by a single nucleo-
tide substitution in the genomic DNA sequence of the gelsolin gene
(GSN), located on chromosome 9. Two gelsolin mutations have
been described: the first and most common mutation, a 654G-A
transition, leads to an Asp to Asn substitution at residue 187 of the
protein. This mutation has been reported in all Finnish patients as
well as in other countries. The second mutation is a 654G-T transver-
sion resulting in a Asp187Tyr substitution and was found in only three
families, of Danish, Czech and French origins, with similar clinical
manifestations(1,2,4-8). We report the first case in a Brazilian family,
carrying the Asp187Tyr mutation, with no known Finnish ancestors.
CASE REPORTS
The family is from Brazil and had no known ancestor from Fin-
land. The grandfather of the proband was born in Armenia. Four
members of this family from two generations were examined.
CASE 1
The proband was a single 58 year-old woman without kids who
presented with gradual reduction in visual acuity of both eyes (OU).
She had a characteristic facial appearance and a history of involun-
tary facial twitching, weakness of the chewing muscles, and a slowly
progressive bilateral facial weakness, associated with loose skin on
the face and head, a drooping forehead and lower lip. Examination
revealed best corrected visual acuity of 20/40 (OU) and she had
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corneal dystrophy with lattice lines primarily in the periphery without
intervening stromal haze, and bilateral corneal hypoesthesia (Figu-
re 1). The proband had only one brother (Case 2).
CASE 2
The 41 year-old brother of the proband had no systemic or visual
complaints. On examination both corneas showed evidence of lattice
lines with bilateral corneal hypoesthesia. This patient has a 9 year old
son and a 3 year old daughter with no abnormalities observed
during their clinical and ophthalmological examination.
The molecular genetic study was done in cases 1, 2 and in the son
of case 2. The genomic DNA was extracted from peripheral blood
lymphocytes using standard techniques. The polymerase chain reac-
tion (PCR) was carried out under standard conditions in 50 μl reaction
volumes, 1 μg of genomic DNA, 0,5 pmol each of forward and reverse
primers, 10 mM of dNTP mix, 10X PCR buffer, 50 mM MgCl
2
, and 0.2
units of Taq platinum polymerase. After an initial denaturation step at
94°C for 5 minutes, the samples were processed through 25 cycles of
amplification consisting of 94°C for 1 minute, primer annealing tem-
perature of 56°C for 1 minute, and extension at 72°C for 1 minute. The
following forward (F) and reverse (R) primers were used: 5‘ - TGGTGG
TGCAGAGACTCTTCC - 3‘ and 5‘- CTTTCATACCGATTGCTGTT- 3‘. Direct
sequencing of purified PCR products was performed using a dye
terminator cycle sequencing kit (Perkin Elmer, Applied Biosystems LTD)
using a fluorescent sequencer (ABI 373), according to the manufac-
turer‘s instructions.
Screening of the genomic DNA showed the G654T mutation in
the gelsolin gene (GSN) in cases 1 and 2. The G substitution by a T
predicts the amino acid substitution of tyrosine for the aspartate at
residue 187 (Figures 2 and 3).
DISCUSSION
Two mutations in the gelsolin gene have been shown to cause
FAF. The most common, a G to A transition at nucleotide 654, has
been detected in all Finnish patients as well as in families of other
nationalities(2,7,9). The second mutation, a G to T transversion at nucleo-
tide 654, has been detected in 3 different families, and is related to
the Danish type of familial amyloidosis, first described in 1979 by
Boysen et al.(2,7-9) In this study we describe for the first time a G654T
mutation in the gelsolin gene in a Brazilian family. The clinical features
of this subtype are very similar to those described by Meretoja (FAF),
presenting skin and neurological changes associated with lattice
corneal dystrophy(2,9-11). The main clinical features of the studied
patients were caused by ophthalmic (cases 1 and 2) and dermato-
logical manifestations (case 1), similar to what is found in FAF.
This result shows that the G654T mutation causes similar clini-
cal findings to those related to the G654A mutation. Previous
studies demonstrated that the substitution of aspartic acid at posi-
tion 187 in gelsolin with either asparagine or tyrosine is associated
with abnormal degradation(2,11) Maury et al., evaluated the Danish
subtype of FAF and report that the immunohistochemical and
biochemical findings indicate that the G654T mutation in the
gelsolin gene gives rise to an amyloid disease clinically and patho-
genetically similar to that caused by the G654A mutation, as obser-
ved in case 1(2).
The disease is an inherited, lifelong chronic condition with sys-
temic symptoms and is probably under-reported. Because the ocu-
lar symptoms are the first to arise, as observed in our cases, the
ophthalmologists should be vigilant. Treatment is symptomatic,
with eye lubricants combined with monitoring of intraocular pres-
sure, and regular ophthalmic examinations are recommended for
all patients with the disease. When systemic symptoms occur, other
specialists should be consulted(12). In our study the DNA analysis
identified the affected patients, which were submitted to frequent
ophthalmic evaluations.
It is important to recognize that this condition can occur in
populations other than in Finnish patients and should be conside-
red in the differential diagnosis of lattice corneal dystrophy. This is
not a true corneal dystrophy and can be confused with true lattice
dystrophies, which in turn may delay diagnosis of the underlying
systemic amyloidosis for many years, especially in populations in
Figure 1. Biomicroscopy showing lattice corneal dystrophy in proband.
Figure 2. Pedigree of family. Affected members are shown in black and those contribu-
ting DNA marked with + symbol.
Figure 3. DNA sequencing showing the G substitution by a T at residue 187.
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which this type of familial amyloidosis is rare(13). To the best of our
knowledge this is the first report of a pedigree of patients with
gelsolin-related familial amyloidosis in Brazil.
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